Left Atrial Appendage Occlusion versus Direct Oral Anticoagulants in the Prevention of Ischaemic Stroke in Patients with Atrial Fibrillation
Cerebrovascular Diseases · 2024
DOI: 10.1159/000536546 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cerebrovascular Diseases, 2024. Verfasst von Sandra Elsheikh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Live…. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Appendage, Atrial Fibrillation, Cardiac Catheterization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Existing randomised controlled trials assessing the safety and efficacy of left atrial appendage occlusion (LAAO) in atrial fibrillation (AF) were of relatively small sample size or included patients who could receive oral anticoagulant treatment after device implantation. We compared the outcomes of patients with newly diagnosed AF who received percutaneous LAAO or direct oral anticoagulant (DOAC) treatment, in a large population from a global federated health network (TriNetX).
Methods
Patients with AF treated with percutaneous LAAO were matched with those treated with DOAC between December 1, 2010, and October 1, 2018. Outcomes were all-cause mortality, ischaemic stroke, and intracranial haemorrhage (ICH) at 5 years.
Results
We included 200 patients with AF, who received either LAAO or DOAC. The risk of all-cause mortality, ischaemic stroke, and ICH at 5 years was not significantly different between the two groups (risk ratio [RR] for all-cause mortality: 1.52, 95% confidence interval (CI): 0.97–2.38, RR for ischaemic stroke: 1.09, 95% CI: 0.51–2.36, and RR for ICH: 1.0, 95% CI: 0.44–2.30).
Conclusion
Patients newly diagnosed with AF, eligible for DOAC, showed similar 5-year risk of death, ischaemic stroke, and ICH when comparing those who underwent percutaneous LAAO to those receiving DOAC. Future randomised controlled trials are needed to confirm the findings and advise changes in guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK, sandramoawia@gmail.com.
- Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK, sandramoawia@gmail.com.
- Mersey and West Lancashire Teaching Hospitals NHS Trust, St Helens, UK, sandramoawia@gmail.com.
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.
- Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
- Department of Basic Science, Prince Sultan Bin Abdulaziz College for Emergency Medical Services, King Saud University, Riyadh, Saudi Arabia.
Zitieren
APA
Elsheikh, S., Alobaida, M., Bucci, T., Buckley, B. J. R., Gupta, D., Irving, G., Hill, A. M., Lip, G. Y. H., & Abdul-Rahim, A. H. (2024). Left Atrial Appendage Occlusion versus Direct Oral Anticoagulants in the Prevention of Ischaemic Stroke in Patients with Atrial Fibrillation. Cerebrovascular Diseases. https://doi.org/10.1159/000536546
Vancouver
Elsheikh S, Alobaida M, Bucci T, Buckley BJR, Gupta D, Irving G, et al. Left Atrial Appendage Occlusion versus Direct Oral Anticoagulants in the Prevention of Ischaemic Stroke in Patients with Atrial Fibrillation. Cerebrovascular Diseases. 2024. doi:10.1159/000536546
BibTeX
@article{Elsheikh2024,
author = {Elsheikh, Sandra and Alobaida, Muath and Bucci, Tommaso and Buckley, Benjamin J R and Gupta, Dhiraj and Irving, Greg and Hill, Andrew M and Lip, Gregory Y H and Abdul-Rahim, Azmil H},
title = {Left Atrial Appendage Occlusion versus Direct Oral Anticoagulants in the Prevention of Ischaemic Stroke in Patients with Atrial Fibrillation},
journal = {Cerebrovascular Diseases},
year = {2024},
doi = {10.1159/000536546}
}
EUVIMED